Posts
Displaying 1 - 13 of 13 results
PCORI announces $150 million in funding for new health research
News Release
WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER)…
Evidence Updates Share New Findings to Support Health Decision Making
Blog
PCORI’s mandate is to improve the quality and relevance of evidence that can help patients, caregivers, clinicians and others make better-informed health or healthcare decisions. Our Evidence Updates are one…
PCORI offers more than $500 million through new funding opportunities
News Release
WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and projects through 10 funding opportunities. Five of these PCORI Funding Announcements (PFAs) are…
PCORI approves $80.5 million for health research using novel approaches to tackle social and clinical care factors that contribute to maternal health inequities
News Release
WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $80.5 million to support four new, ambitious patient-centered comparative clinical effectiveness research (CER) studies focused on…
PCORI approves $225 million in funding for dozens of health research studies and related projects
News Release
WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling $225 million, which include $207 million to support 20 new patient-centered comparative clinical…
PCORI approves $208 million for research on heart disease, chronic disease, palliative care and a range of conditions impacting people of all ages
News Release
WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $208 million to support 17 new comparative clinical effectiveness research (CER) studies, including four trials of…
PCORI approves $123 million for research on postpartum care, hypertension management, antibiotic prescribing and a range of conditions
News Release
WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $123 million to support 15 new research studies. These studies aim to fill evidence gaps, enhance…
PCORI offers up to $467 million through new research funding opportunities on research topics
News Release
WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through nine funding opportunities. These PCORI Funding Announcements (PFAs) include up…
Funding Opportunities Focused on Management of Multiple Chronic Conditions, Healthy Aging, Results Implementation, and More Open September 7
Blog
PCORI’s third funding cycle of the year opens September 7, seeking projects that answer questions about the most effective treatments for a variety of topics, study the best ways to…
Community Activist's Work Influenced by Service on PCORI Advisory Panel
Blog
My time on the PCORI Patient Engagement Advisory Panel (PEAP), as both a member and chair from 2017 to 2020, has had a tremendous impact on my thinking about patient…
Can Some MS Patients Safely Stop Taking Medicines?
Blog
Multiple sclerosis is an often disabling neurological condition that affects about 400,000 people in the United States. People with MS can develop a wide variety of symptoms, including vision problems…
A Multifaceted Disease Requires a Patient-Centered Response
Blog
In 1986, I began experiencing bouts of numbness, fatigue, and lack of coordination on my left side. Those symptoms launched my 13-year journey toward a diagnosis of multiple sclerosis, or…
Can Patients with MS Safely Stop Taking Medicine as They Age? DISCOMS Trial's Results Indicate It's a Reasonable Option for Some
Research Study Highlight
Although new results from an ongoing PCORI-funded study into whether some patients with multiple sclerosis (MS) can safely stop taking certain kinds of medications as they age weren’t conclusive in…